Market Overview:
The global endoscope + radiofrequency ablation (RFA) market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of target diseases, technological advancements in endoscopic devices and growing demand for minimally invasive surgeries. Based on type, the focal ablation segment is expected to account for the largest share of the global endoscope + RFA market in 2018. This segment is also projected to grow at a higher CAGR during the forecast period owing to its advantages over other types of ablations such as thermal and cryoablation. By application, cardiology application is expected to account for the largest share of the global endoscope + RFA market in 2018.
 Industry Outlook.svg)
Product Definition:
An endoscope is a thin, flexible tube with a light and camera at one end that doctors use to see inside the body. A radiofrequency ablation (RFA) is a type of surgery that uses heat to destroy cancer cells.
Focal Ablation:
Focal ablation is a minimally invasive surgical procedure used to treat patients suffering from glaucoma, cataract, and other refractive errors. This procedure involves the use of heat to destroy tissue in the eye. The process is done under local anesthesia with or without sedation and can be performed on an outpatient basis.
Others:
Others is the market for all the accessories and parts that are not included in endoscope and radiofrequency ablation. Others market includes products such as catheters, guidewires, dilators, access needles & cannula sets, thermometers & temperature probes. The others segment is expected to grow at a lucrative CAGR during the forecast period owing to factors such as increasing prevalence of cancer coupled with rising demand for minimally invasive procedures due to reduced post-operative complications.
Application Insights:
The other application segment held the largest share of the global endoscope + RFA market in 2017. This is due to an increase in demand for minimally invasive surgeries for various diseases, such as urinary tract infections and kidney stones. According to a study published by NCBI, around 1 million kidney stone surgeries are performed annually. In addition, another study states that around 2% of men and 0.5% of women will develop a urinary tract infection (UTI) during their lifetime. Thus, increasing incidences of UTIs and kidney stones may boost the usage rate of endoscopic procedures across various medical specialties over the forecast period., Endoscopic procedures are also used commonly for pain management owing to its non-invasive nature., However, cardiology application is expected to be at fastest growth rate during the forecast period due largely to an increase in demand for minimally invasive cardiac procedures across all age groups globally.
Regional Analysis:
North America dominated the global endoscope + radiofrequency ablation market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of highly skilled physicians and advanced medical devices. Moreover, increasing prevalence of cancer is also expected to drive regional growth over the forecast period. For instance, according to statistics published by American Cancer Society in 2018, around 1,762 new cases were reported in New York state alone during 2015-2016.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure coupled with economic development within countries such as China & India and other Southeast Asian nations such as Indonesia & Malaysia etc.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the Endoscope + Radiofrequency Ablation (RFA) market. According to a study by the World Health Organization (WHO), it is estimated that around 14 million new cases of cancer will be diagnosed in 2020, out of which 8 million will die from the disease. This number is expected to rise in future due to increase in aging population and lifestyle changes.
- Rising demand for minimally invasive surgeries: The demand for minimally invasive surgeries is rising due to their advantages over traditional open surgery such as shorter hospital stay, reduced pain, and faster recovery time. This is driving the growth of Endoscope + Radiofrequency Ablation (RFA) market as these devices are used during minimally invasive surgeries.
- Technological advancements: The technological advancements in endoscopy devices are helping to improve their performance and accuracy thus driving the growth of Endoscope + Radiofrequency Ablation (RFA) market . For instance, recent advancements such as use of high-resolution optics and miniaturization have made endoscopes more versatile and easier to use thus increasing their adoption rates among surgeons worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Endoscope + Radiofrequency Ablation (RFA) Market Research Report
By Type
Focal Ablation, Others
By Application
Cardiology Application, Pain Management, Oncology Application, Other Application
By Companies
Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic, AtriCure
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Endoscope + Radiofrequency Ablation (RFA) Market Report Segments:
The global Endoscope + Radiofrequency Ablation (RFA) market is segmented on the basis of:
Types
Focal Ablation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiology Application, Pain Management, Oncology Application, Other Application
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific Corporation Conmed Corporation
- Medtronic Plc (Covidien Plc)
- Smith and Nephew Plc
- Stryker Corporation
- Halyard Health
- Abbott Laboratories (St. Jude Medical, Inc.)
- AngioDynamics
- Hologic
- AtriCure
 Market Overview.svg)
Highlights of The Endoscope + Radiofrequency Ablation (RFA) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Focal Ablation
- Others
- By Application:
- Cardiology Application
- Pain Management
- Oncology Application
- Other Application
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endoscope + Radiofrequency Ablation (RFA) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endoscopic + radiofrequency ablation (RFA) is a minimally invasive treatment for benign prostatic hyperplasia (BPH). It uses an endoscope to view the prostate and then uses radiofrequency energy to destroy the enlarged prostate.
Some of the key players operating in the endoscope + radiofrequency ablation (rfa) market are Boston Scientific Corporation Conmed Corporation, Medtronic Plc (Covidien Plc), Smith and Nephew Plc, Stryker Corporation, Halyard Health, Abbott Laboratories (St. Jude Medical, Inc.), AngioDynamics, Hologic, AtriCure.
The endoscope + radiofrequency ablation (rfa) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endoscope + Radiofrequency Ablation (RFA) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endoscope + Radiofrequency Ablation (RFA) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endoscope + Radiofrequency Ablation (RFA) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endoscope + Radiofrequency Ablation (RFA) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endoscope + Radiofrequency Ablation (RFA) Market Size & Forecast, 2020-2028
4.5.1 Endoscope + Radiofrequency Ablation (RFA) Market Size and Y-o-Y Growth
4.5.2 Endoscope + Radiofrequency Ablation (RFA) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Focal Ablation
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiology Application
6.2.2 Pain Management
6.2.3 Oncology Application
6.2.4 Other Application
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endoscope + Radiofrequency Ablation (RFA) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endoscope + Radiofrequency Ablation (RFA) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Focal Ablation
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiology Application
9.10.2 Pain Management
9.10.3 Oncology Application
9.10.4 Other Application
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Focal Ablation
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiology Application
10.10.2 Pain Management
10.10.3 Oncology Application
10.10.4 Other Application
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Focal Ablation
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiology Application
11.10.2 Pain Management
11.10.3 Oncology Application
11.10.4 Other Application
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Focal Ablation
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiology Application
12.10.2 Pain Management
12.10.3 Oncology Application
12.10.4 Other Application
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Focal Ablation
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiology Application
13.10.2 Pain Management
13.10.3 Oncology Application
13.10.4 Other Application
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endoscope + Radiofrequency Ablation (RFA) Market: Competitive Dashboard
14.2 Global Endoscope + Radiofrequency Ablation (RFA) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific Corporation Conmed Corporation
14.3.2 Medtronic Plc (Covidien Plc)
14.3.3 Smith and Nephew Plc
14.3.4 Stryker Corporation
14.3.5 Halyard Health
14.3.6 Abbott Laboratories (St. Jude Medical, Inc.)
14.3.7 AngioDynamics
14.3.8 Hologic
14.3.9 AtriCure
